Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00192 |
| Species: | Homo sapiens |
| Position : | chr3:168915400-168918000 |
| Year: | 2021 |
| Title: | The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 34584081 |
| MONDO: | |
| Tissue: | Peripheral Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | Human B lymphoblastoid cell |
| CVCL ID: | |
| Cell Type: | B lymphoblastoid cell |
| Cell Ontology ID: | CL:0000945 |
| Experiment Type: | Functional perturbation assay, Chromatin interaction assay, TF binding assay |
| High Throughput Method: | ChIP-seq, 4C-seq, RNA-seq |
| Low Throughput Method: | CRISPR KO, RT-RT-qPCR, Western blot |
| Target gene : | EVI1 |
| TF name : | CTCF |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| CTCF | Activation of anterior HOX genes in hindbrain development during early embryogenesis | reactome | 120 |
| CTCF | TGF_beta_Receptor | netpath | 220 |
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_00193 | chr3:168915400-168918000 | Blood | T lymphoblast | T-cell acute lymphoblastic leukemia |